![Des-Arg9-[Leu8]-Bradykinin acetate](https://file.medchemexpress.com/product_pic/hy-p3209.gif "Click to View Des-Arg9-[Leu8]-Bradykinin acetate Product Detail")
![[Des-Arg10]-HOE I40 TFA](https://file.medchemexpress.com/product_pic/hy-p5518a.gif "Click to View [Des-Arg10]-HOE I40 TFA Product Detail")
![[D-Arg1,D-Trp5,7,9,Leu11]-Substance P](https://file.medchemexpress.com/product_pic/hy-p11405.gif "Click to View [D-Arg1,D-Trp5,7,9,Leu11]-Substance P Product Detail")
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
49 Results for "
bradykinin antagonist
" in MedChemExpress (MCE) Product Catalog:
Products (49)
49 Results for "bradykinin antagonist" in MCE Product Catalog:
14
Target:
Research Areas:
14
14 Cited Publications
Synonyms: HOE 140 acetate
Target:
Research Areas:
2
2 Cited Publications
Target:
Research Areas:
SSR240612 is a potent, and orally active specific non-peptide bradykinin B1 receptor antagonist, with Kis of 0.48 nM and 0.73 nM for B1 kinin receptors of human fibroblast MRC5 and HEK cells expressing human B1 receptors, 481 nM and 358 nM for B2 receptors of guinea pig ileum membranes and CHO cells expressing human B1 receptor, respectively.
Target:
Research Areas:
Target:
Research Areas:
ELN-441958 is a potent, neutral, competitive and selective bradykinin B1 receptor antagonist with a Ki of 0.26 nM against native human bradykinin B1 receptor. ELN-441958 has high oral bioavailability, and has low CNS exposure in the mouse .
Cat. No.: HY-W704574
CAS No.: 77102-28-4
Research Areas:
Mergetpa is a reversible Arg-carboxypeptidase inhibitor with high affinity. Mergetpa reduces B1R. Mergetpa blocks the overexpression of IL-1β protein and mRNA in glucose-fed rats. Mergetpa significantly increases the expression of IL-1β protein in the renal cortex. Mergetpa is used to block the conversion of kinins and B2 receptor antagonists into metabolites lacking the C-terminal arginine. Mergetpa inhibits the time-dependent enhancement of the response of isolated rabbit aorta to bradykinin. Mergetpa preserves the chemotactic activity of full-length SDF-1α on cells. Mergetpa reverses hyperglycemia, excessive weight gain, elevated levels of oxidative stress markers and overexpression of inflammatory markers in glucose-fed rats .
Cat. No.: HY-168906
CAS No.: 1119282-90-4
Target:
Research Areas:
BI-113823 is an orally active, blood-brain barrier-permeable bradykinin B1 receptor antagonist, with a Ki value of 5.3 nM for human receptors and 13.3 nM for rat receptors. BI-113823 reduces inflammation-induced mechanical hyperalgesia, as well as the mechanical sensitivity of peripheral afferent nerves and spinal nociceptive-specific neurons. BI-113823 alleviates liver fibrosis and portal hypertension, and improves survival in chronic liver disease models. BI-113823 inhibits the activities of monocytes, neutrophils and hepatic stellate cells, as well as the PI3K/Akt signaling pathway. BI-113823 can be used in research related to inflammatory pain, liver fibrosis and portal hypertension .
Cat. No.: HY-121156A
CAS No.: 209788-45-4
Synonyms: LF 16-0687 hydrochloride; XY-2405 hydrochloride
Target:
Research Areas:
Anatibant (LF 16-0687; XY-2405) hydrochloride is a selective non-peptide bradykinin B2 receptor antagonist. Anatibant hydrochloride binds to the human, rat and guinea-pig recombinant B2 receptor with Ki values of 0.67 nM, 1.74 nM and 1.37 nM, respectively. Anatibant hydrochloride crosses the blood-brain barrier (BBB). Anatibant hydrochloride can be used in research on brain damage diseases .
Cat. No.: HY-P4676
CAS No.: 71800-37-8
Target:
Research Areas:
Target:
Research Areas:
Fulimetibant is a Bradykinin receptor antagonist .
Cat. No.: HY-W041989
CAS No.: 130309-37-4
Target:
Research Areas:
Cat. No.: HY-P3209
CAS No.: 115035-45-5
Target:
Research Areas:
Cat. No.: HY-P1185
CAS No.: 115150-59-9
Target:
Research Areas:
Cat. No.: HY-P5518A
Target:
Research Areas:
Cat. No.: HY-15791
CAS No.: 167838-64-4
Synonyms: FK-3657
Target:
Research Areas:
FR173657 is an orally active bradykinin B2 receptor antagonist (IC50: 0.56, 1.5, 2.9 nM for pig, rat, human B2 receptor respectively). FR173657 (p.o.) inhibits BK-induced bronchoconstriction in guinea-pigs (ED50: 0.075 mg/kg). FR173657 (p.o.) also inhibits Carrageenin-induced paw oedema in mice (ED50: 6.8 mg/kg). FR173657 can be used for research of inflammatory disease .
Cat. No.: HY-121156
CAS No.: 209733-45-9
Synonyms: LF 16-0687; XY-2405
Target:
Research Areas:
Anatibant (LF 16-0687; XY-2405) is a selective non-peptide bradykinin B2 receptor antagonist. Anatibant binds to the human, rat and guinea-pig recombinant B2 receptor with Ki values of 0.67 nM, 1.74 nM and 1.37 nM, respectively. Anatibant crosses the blood-brain barrier (BBB). Anatibant can be used in research on brain damage diseases .
Cat. No.: HY-158262
CAS No.: 578727-81-8
Target:
Research Areas:
Bradykinin B1 receptor antagonist 1 (compound 6B) is a potent and cross the blood-brain barrier bradykinin B1 antagonist. Bradykinin B1 receptor antagonist 1 has the potential for the research of pain .
Cat. No.: HY-P11405
CAS No.: 122481-75-8
Target:
Research Areas:
Cat. No.: HY-101368A
CAS No.: 163727-74-0
Target:
Research Areas:
WIN 64338 hydrochloride is a potent, selective, nonpeptide competitive antagonist of bradykinin B2 receptor. WIN 64338 hydrochloride inhibits [ 3H]-Bradykinin binding to the bradykinin B2 receptor on human IMR-90 cells with a Ki of 64 nM. WIN 64338 hydrochloride also can inhibits [ 3H]Quinuclidinyl benzilate binding to the rat brain muscarinic receptor (Ki=350 nM) .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
